David Regan

David joined Sona Nanotech as a consultant in the spring of 2020 to provide strategic advisory with respect to its commercialization and capital markets strategies as the company plotted a path toward developing and taking its COVID-19 test to market. In July of 2020, he was named CEO with the mandate to secure third-party evaluations of the test, manufacturing capacity via contract manufacturing organizations, regulatory approvals and, ultimately, sales.

He has 25 years of experience in finance, international business, innovation, M&A, and capital markets. He has previously led corporate strategy and M&A function at a dual-listed public company, been an innovation consultant, and provided financial advisory services.

Location

Halifax, Canada

Links


Org chart


Teams


Offices

This person is not in any offices


Sona Nanotech

Sona Nanotech produces high-quality, unique gold nanorod products for diagnostic tests and medical treatment applications. Their non-toxic nanorods are synthesized without CTAB and will power the next generation of lateral flow diagnostics.


Industries

Headquarters

Dartmouth, Canada

Employees

11-50

Links